Literature DB >> 31186346

Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function.

Yiran Li1, Wenjia Lou1, Vaishnavi Raja1, Simone Denis2,3,4, Wenxi Yu1, Michael W Schmidtke1, Christian A Reynolds1, Michael Schlame5,6, Riekelt H Houtkooper2,3,4, Miriam L Greenberg7.   

Abstract

Cardiolipin (CL) is the signature phospholipid of mitochondrial membranes. Although it has long been known that CL plays an important role in mitochondrial bioenergetics, recent evidence in the yeast model indicates that CL is also essential for intermediary metabolism. To gain insight into the function of CL in energy metabolism in mammalian cells, here we analyzed the metabolic flux of [U-13C]glucose in a mouse C2C12 myoblast cell line, TAZ-KO, which is CL-deficient because of CRISPR/Cas9-mediated knockout of the CL-remodeling enzyme tafazzin (TAZ). TAZ-KO cells exhibited decreased flux of [U-13C]glucose to [13C]acetyl-CoA and M2 and M4 isotopomers of tricarboxylic acid (TCA) cycle intermediates. The activity of pyruvate carboxylase, the predominant enzyme for anaplerotic replenishing of the TCA cycle, was elevated in TAZ-KO cells, which also exhibited increased sensitivity to the pyruvate carboxylase inhibitor phenylacetate. We attributed a decreased carbon flux from glucose to acetyl-CoA in the TAZ-KO cells to a ∼50% decrease in pyruvate dehydrogenase (PDH) activity, which was observed in both TAZ-KO cells and cardiac tissue from TAZ-KO mice. Protein-lipid overlay experiments revealed that PDH binds to CL, and supplementing digitonin-solubilized TAZ-KO mitochondria with CL restored PDH activity to WT levels. Mitochondria from TAZ-KO cells exhibited an increase in phosphorylated PDH, levels of which were reduced in the presence of supplemented CL. These findings indicate that CL is required for optimal PDH activation, generation of acetyl-CoA, and TCA cycle function, findings that link the key mitochondrial lipid CL to TCA cycle function and energy metabolism.
© 2019 Li et al.

Entities:  

Keywords:  cardiolipin; mitochondria; pyruvate carboxylase (PC); pyruvate dehydrogenase complex (PDC); tricarboxylic acid cycle (TCA cycle) (Krebs cycle)

Mesh:

Substances:

Year:  2019        PMID: 31186346      PMCID: PMC6663869          DOI: 10.1074/jbc.RA119.009037

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes.

Authors:  L J Reed
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

2.  Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites.

Authors:  E Kolobova; A Tuganova; I Boulatnikov; K M Popov
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

3.  Probing the mechanism of inactivation of human pyruvate dehydrogenase by phosphorylation of three sites.

Authors:  L G Korotchkina; M S Patel
Journal:  J Biol Chem       Date:  2000-11-22       Impact factor: 5.157

4.  3-Hydroxy-3-methylglutaric aciduria: 3-hydroxy-3-methylglutaryl-coenzyme A lyase levels in leucocytes.

Authors:  S J Wysocki; R Hähnel
Journal:  Clin Chim Acta       Date:  1976-12-01       Impact factor: 3.786

Review 5.  Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms.

Authors:  T E Roche; J C Baker; X Yan; Y Hiromasa; X Gong; T Peng; J Dong; A Turkan; S A Kasten
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

6.  Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function.

Authors:  F Jiang; M T Ryan; M Schlame; M Zhao; Z Gu; M Klingenberg; N Pfanner; M L Greenberg
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

7.  Demonstration of a new mammalian isoleucine catabolic pathway yielding an Rseries of metabolites.

Authors:  O A Mamer; S S Tjoa; C R Scriver; G A Klassen
Journal:  Biochem J       Date:  1976-12-15       Impact factor: 3.857

Review 8.  X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)-MIM 302060.

Authors:  P G Barth; R J Wanders; P Vreken
Journal:  J Pediatr       Date:  1999-09       Impact factor: 4.406

9.  Protein lipid overlay assay.

Authors:  Simon Dowler; Gursant Kular; Dario R Alessi
Journal:  Sci STKE       Date:  2002-04-23

10.  Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome.

Authors:  Michael Schlame; Jeffrey A Towbin; Paul M Heerdt; Roswitha Jehle; Salvatore DiMauro; Thomas J J Blanck
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

View more
  9 in total

1.  Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.

Authors:  Catherine H Le; Lindsay G Benage; Kalyn S Specht; Lance C Li Puma; Christopher M Mulligan; Adam L Heuberger; Jessica E Prenni; Steven M Claypool; Kathryn C Chatfield; Genevieve C Sparagna; Adam J Chicco
Journal:  J Biol Chem       Date:  2020-07-14       Impact factor: 5.157

Review 2.  Cardiolipin function in the yeast S. cerevisiae and the lessons learned for Barth syndrome.

Authors:  Jiajia Ji; Miriam L Greenberg
Journal:  J Inherit Metab Dis       Date:  2021-10-19       Impact factor: 4.982

3.  MCU-complex-mediated mitochondrial calcium signaling is impaired in Barth syndrome.

Authors:  Sagnika Ghosh; Mohammad Zulkifli; Alaumy Joshi; Manigandan Venkatesan; Allen Cristel; Neelanjan Vishnu; Muniswamy Madesh; Vishal M Gohil
Journal:  Hum Mol Genet       Date:  2022-02-03       Impact factor: 5.121

4.  NAD supplementation improves mitochondrial performance of cardiolipin mutants.

Authors:  Jiajia Ji; Deena Damschroder; Denise Bessert; Pablo Lazcano; Robert Wessells; Christian A Reynolds; Miriam L Greenberg
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2022-01-18       Impact factor: 4.698

Review 5.  Metabolic Alterations Caused by Defective Cardiolipin Remodeling in Inherited Cardiomyopathies.

Authors:  Christina Wasmus; Jan Dudek
Journal:  Life (Basel)       Date:  2020-11-11

Review 6.  Studying Lipid-Related Pathophysiology Using the Yeast Model.

Authors:  Tyler Ralph-Epps; Chisom J Onu; Linh Vo; Michael W Schmidtke; Anh Le; Miriam L Greenberg
Journal:  Front Physiol       Date:  2021-10-28       Impact factor: 4.566

Review 7.  Myocardial disturbances of intermediary metabolism in Barth syndrome.

Authors:  Amanda A Greenwell; Seyed Amirhossein Tabatabaei Dakhili; John R Ussher
Journal:  Front Cardiovasc Med       Date:  2022-08-10

8.  Barth Syndrome: Exploring Cardiac Metabolism with Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Erica M Fatica; Gina A DeLeonibus; Alisha House; Jillian V Kodger; Ryan W Pearce; Rohan R Shah; Liraz Levi; Yana Sandlers
Journal:  Metabolites       Date:  2019-12-17

Review 9.  Cardiolipin, the Mitochondrial Signature Lipid: Implication in Cancer.

Authors:  Seyedeh Tayebeh Ahmadpour; Karine Mahéo; Stéphane Servais; Lucie Brisson; Jean-François Dumas
Journal:  Int J Mol Sci       Date:  2020-10-28       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.